| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Oct-08 | | Total Revenue | 7,550 | 7,580 | 2,022 | 4,236 | | Cost of Revenue | 5,762 | 5,663 | 2,336 | 3,777 | | | Gross Profit | 1,788 | 1,917 | (314) | 459 | | | Operating Expenses | | Research Development | 1,018 | 972 | 870 | 1,824 | | Selling General and Administrative | 1,242 | 1,597 | 1,686 | 3,100 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (472) | (652) | (2,870) | (4,465) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (4) | 17 | (10) | 24 | | Earnings Before Interest And Taxes | (476) | (635) | (2,880) | (4,441) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (476) | (635) | (2,880) | (4,441) | | Income Tax Expense | (59) |
-
|
-
| (32) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (417) | (635) | (2,880) | (4,409) | | | Non-recurring Events | | Discontinued Operations | (9) | (27) | 39 | 50 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (426) | (662) | (2,841) | (4,359) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($426) | ($662) | ($2,841) | ($4,359) |
|
0.02% Nasdaq 
Income Statement
